Circulating platelet microparticles in patients with antiphospholipid antibodies.

被引:0
|
作者
Hunt, BJ [1 ]
O'Mahony, A [1 ]
Parmamr, K [1 ]
机构
[1] Guys & St Thomas Trust, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4165
引用
收藏
页码:114B / 114B
页数:1
相关论文
共 50 条
  • [41] The Global Antiphospholipid Syndrome Score (GAPSS) Differentiates Between Transient Ischemic Attack and Stroke in Patients with Antiphospholipid Antibodies.
    Sciascia, Savino
    Sanna, Giovanni
    Murru, Veronica
    Roccatello, Dario
    Khamashta, Munther A.
    Bertolaccini, Maria Laura
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S718 - S718
  • [42] ELEVATED CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH LUNG CANCER
    Tseng, Jo Chi
    Hua, Chung Ching
    Jiang, Bor Yiing
    Chen, Hung Jie
    Liu, Yu Chih
    Yu, Chih Teng
    Tseng, Ching Ping
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S948 - S949
  • [43] Reply to: "Circulating platelet derived microparticles are not increased in patients with cirrhosis"
    Tapper, Elliot B.
    Robson, Simon
    Malik, Raza
    JOURNAL OF HEPATOLOGY, 2013, 59 (04) : 913 - 913
  • [44] The Protective Effects of Statins for Thrombosis in Patients with Systemic Lupus Erythematosus Positive for Antiphospholipid Antibodies.
    Watanabe, Toshiyuki
    Oku, Kenji
    Amengual, Olga
    Sugawara, Eri
    Hisada, Ryo
    Ohmura, Kazumasa
    Fukui, Tomoko
    Shimamura, Sanae
    Nakagawa, Ikuma
    Noguchi, Atsushi
    Shida, Haruki
    Kono, Michihito
    Shimizu, Yuka
    Kurita, Takashi
    Bohgaki, Toshiyuki
    Horita, Tetsuya
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1154 - S1155
  • [45] Renal damage in patients with biopsy-proven lupus nephritis: Effect of antiphospholipid antibodies.
    Irastorza, GR
    Pisoni, CN
    Egurbide, MV
    Aguirre, C
    Hughes, GRV
    Khamashta, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S384 - S384
  • [46] Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies.
    Zangari, M
    Lockwood, CJ
    Scher, J
    Rand, JH
    THROMBOSIS RESEARCH, 1997, 85 (03) : 177 - 183
  • [47] Factor V Leiden, prothrombin gene mutations and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra, N
    Koren, S
    Greer, WL
    Fortin, PR
    Rauch, J
    Fortin, I
    Senecal, JL
    Docherty, P
    Hanly, JG
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S312 - S312
  • [48] Identification of platelet phosphoproteins recognized by the platelet panel of monoclonal antibodies.
    Campbell, KD
    Skubitz, APN
    Skubitz, KM
    TISSUE ANTIGENS, 1996, 48 (4-II): : PL505 - PL505
  • [49] Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?
    Rotar, Z.
    Rozman, B.
    de Groot, P. G.
    Sanmarco, M.
    Shoenfeld, Y.
    Meroni, P. L.
    Cervera, R.
    Pengo, V.
    Cimaz, R.
    Avcin, T.
    Carp, H. J. A.
    Tincani, A.
    LUPUS, 2009, 18 (01) : 53 - 60
  • [50] Thromboembolism in parenteral nutrition: Association with intravenous fat and antiphospholipid antibodies.
    Berant, M
    Shah, V
    BenBarak, A
    Lanir, N
    Dollery, C
    Milla, PC
    PEDIATRIC RESEARCH, 1996, 39 (04) : 680 - 680